Kevin Charles Gorman, a director at Neurocrine Biosciences Inc. (NASDAQ:NBIX), sold a total of 5,844 shares of the company's common stock on February 13, 2025, according to a recent SEC filing. The ...

CEO Ralf Wunderlich, newly appointed in January 2025, emphasized the company's commitment to its 2030 strategy, highlighting three key priorities: accelerating profitable growth, disciplined capital ...

Trump ‘is not willing to tolerate’ VAT, US president’s trade chief says, raising fears UK could face 21 per cent tax ...

Deutsche Bank’s shift to Google Cloud powers up its AI capabilities, optimising operations and slashing process times ...

Ryan Krueger, KBW: Queried the baseline for EPS growth targets. CFO Elias Habayeb clarified that the reported EPS of $4.83, adjusted for notable items and variable investment income, serves as the ...

A group of CEOs from leading U.S. banks are meeting with the Senate Banking Committee to discuss potential solutions to regulatory issues related to debanking decisions.

U.S. President Donald Trump in an all-caps post on Truth Social Thursday teased a new round of sweeping reciprocal tariffs, ...

Good day, ladies and gentlemen, and welcome to the MedPace fourth-quarter and full-year 2024 earnings conference call. (Operator Instructions) As a reminder, this call is being recorded. And now I'd ...

The partners paid about $56 million, or roughly $170 per square foot, to buy 505 North Brand Boulevard from Cruzan and Goldman Sachs Private Real […]This article originally appeared on The Real Deal.

The tech mogul is unlikely to win. But his goal may be more about making life difficult for the A.I. start-up and its leader, ...